Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acu-D3 is a dietary supplement containing Vitamin D3 (cholecalciferol), a fat-soluble prohormone essential for maintaining overall health. Vitamin D3 is crucial for the regulation of calcium and phosphorus levels in the body, primarily by promoting their absorption in the intestines and mobilization from bone. After being metabolized in the liver and kidneys to its active form, calcitriol, it binds to the Vitamin D Receptor (VDR), influencing gene transcription. This action supports bone health by facilitating bone mineralization and preventing conditions like osteoporosis and rickets. Beyond its role in bone metabolism, Vitamin D3 also plays a significant part in immune system function, cell growth, and differentiation. Acu-D3 products are typically used to treat or prevent Vitamin D deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Acu-D3.